JPMA Takes Issue with WTO IP Waiver Proposal for COVID Vaccines

May 13, 2022
The Japan Pharmaceutical Manufacturers Association (JPMA) issued a statement on May 11 opposing a proposed deal to waive intellectual property protections for COVID-19 vaccines, which was put forward to a World Trade Organization (WTO) council earlier this month. The so...read more